Related Experiment Video
Updated: Jul 23, 2025

06:33
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
1.3K
A case of high-risk AML in a patient with advanced systemic mastocytosis
Manlio Fazio1, Calogero Vetro2, Uroš Markovic2
1Post Graduation School of Hematology University of Catania, A.O.U. Policlinico "G.Rodolico-San Marco" Catania Italy.
Clinical Case Reports
|July 20, 2023
Abstract:
Aggressive SM + AML has limited therapeutic options. Even a strong combination of decitabine-venetoclax-midostaurin has a transient effect on AML and a mitigated effect on SM. Larger series are required to identify the best therapeutic strategy.

